Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 5, 2005, Pages 1208-1215

  Hiransuthikul, Narin ^a   Hiransuthikul, Pornthip ^a   Nelson, Kenrad E ^b   Jirawisit, Mayuri ^a   Paewplot, Rawadi ^a   Kasak, Supawan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30344472135     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anonymous. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999; 74: 385-98.
2. Anonymous. Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO). Tuber Lung Dis 1994; 75: 96-8.
3. de Colombani P, Banatvala N, Zaleskis R, Maher D. European framework to decrease the burden of TB/HIV. Eur Respir J 2004; 24: 493-501.
4. De Riemer K, Daley CL, Reingold AL. Preventing tuberculosis among HIV-infected persons: a survey of physicians' knowledge and practices. Prev Med 1999; 28: 437-44.
5. Department of Communicable Diseases Control, MOPH, Thailand, and World Health Organization. 2nd Review of the National Tuberculosis Program in Thailand. Bangkok: Ministry of Public Health, 1999.
6. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-20.
7. Gillini L, Seita A. Tuberculosis and HIV in the Eastern Mediterranean Region. East Mediterr Health J 2002; 8: 699-705.
8. Gordin F, Chaisson RE, Matts JP, et al. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. JAMA 2000; 283: 1445-50.
9. Guelar A, Gatell JM, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-9.
10. Hawken M, Nganga L, Meme H, Chakaya J, Porter J. Is cough alone adequate to screen HIV-positive persons for tuberculosis preventive therapy in developing countries? Int J Tuberc Lung Dis 1999; 3: 540-1.
11. Hawken MP, Meme HK, Elliott LC, et al. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS 1997; 11: 875-82.
12. Hiransuthikul N, Nelson KE HP, Paeplot R, Vorayingyong A. INH preventive therapy among Thai adult HIV-infected patients. Int J Tuberc Lung Dis 2004.
13. Hong Kong Chest Service/Tuberculosis Research Center, Madras/British Medical Research Council. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145: 36-41.
14. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000; 55: 887-901.
15. Leonard MK, Larsen N, Drechsler H, et al. Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000. Clin Infect Dis 2002; 34: 1002-7.
16. Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-8.
17. Mwinga A, Hosp M, Godfrey-Faussett P, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12: 2447-57.
18. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res 2004; 120: 277-89.
19. Natrapan C, Akrasewi P KS, Prapanwong A. Feasibility of INH preventive therapy In HIV-Infected persons, Chiangmai, Thailand: first year report. Vancouver: XI International Conference on AIDS. July 7-12, 1996.
20. Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS 1997; 11: 107-12.
21. Payananda V. Information in preparation for an external review of the national program, Thailand. Bangkok, 1995: 27-35.
22. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ 1992; 70: 515-26.
23. Sackoff JE, Torian LV, Frieden TR, Brudney KF, Menzies IB. Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS 1998; 12: 2017-23.
24. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-20.
25. Wilkinson D. Drugs for preventing tuberculosis in HIV infected persons. Cochrane Database Syst Rev 2000: CD000171.
26. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 2003; 301: 1535-7.
27. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004: CD000171.